Advanced Enzyme Tech Current Share Price | Advanced Enzyme Tech Stock Screener
ADVENZYMES
Biotechnology
Advanced Enzyme Tech Current Stock Price Today
Live Share Price NSE
₹305.20
▲
2.20 (0.73%)
Live Share Price BSE
₹305.30
▲
2.05 (0.68%)
As of August 19, 2026, the live Advanced Enzyme Tech share price (NSE: ADVENZYMES) is ₹305.20 on NSE and ₹305.30 on BSE, up 0.73% from the previous close, with shares trading between ₹302.00 and ₹307.65 in today's trading session, and a 52-week range of ₹255.30–₹392.10.
Analyse ADVENZYMES share price history and track historical price performance.
Use the Advanced Enzyme Tech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Advanced Enzyme Tech Market Cap
₹3,399.60 Cr.
ADVENZYMES P/E Ratio (TTM)
19.90
Advanced Enzyme Tech P/B Ratio
2.09
EPS (TTM)
₹15.08
Dividend Yield
1.75%
Debt to Equity
0.02
ADVENZYMES 52 Week High
₹392.10
Advanced Enzyme Tech 52 Week Low
₹255.30
Operating Margin
31.00%
Profit Margin
21.33%
ADVENZYMES Revenue (TTM)
₹211.00
EBITDA
₹71.00
Net Income
₹45.00
Total Assets
₹1,839.00
Total Equity
₹1,683.00
Advanced Enzyme Tech Current Share Price Chart
Track the current Advanced Enzyme Tech share price and stock price with an interactive chart. Analyse ADVENZYMES price trends, trading volume, historical performance, and volatility across different timeframes — the complete Advanced Enzyme Tech stock quote in one place.
Advanced Enzyme Tech Company Profile - Fundamental Screener
Screen Advanced Enzyme Tech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ADVENZYMES shares.
Sector
Healthcare
Industry
Biotechnology
Sub-Sector
Biotechnology
Segment
E
ISIN
INE837H01020
Advanced Enzyme Tech Balance Sheet Screener
Screen ADVENZYMES balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,839 | 1,621 | 1,536 | 1,422 | 1,268 | 1,153 | 979 | 811 | 732 | 589 |
| Current Assets | 1,044 | 880 | 810 | 722 | 604 | 516 | 376 | 282 | 211 | 138 |
| Fixed Assets | 692 | 679 | 650 | 649 | 619 | 601 | 563 | 496 | 491 | 421 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 49 | 56 | 58 | 60 | 67 | 54 | 52 | 41 | 51 | 42 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,683 | 1,469 | 1,371 | 1,284 | 1,140 | 1,031 | 867 | 705 | 582 | 485 |
| Share Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves & Surplus | 1,609 | 1,399 | 1,302 | 1,213 | 1,066 | 948 | 817 | 657 | 537 | 442 |
Advanced Enzyme Tech Income Statement Screener - Profit & Revenue Analysis
Screen Advanced Enzyme Tech income statement and profit fundamentals.
Analyze ADVENZYMES quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Advanced Enzyme Tech share price evaluation.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 211 | 203 | 176 | 195 | 195 | 192 | 167 | 162 | 156 | 177 | 150 | 154 | 164 | 175 | 135 |
| Expenses | 140 | 139 | 122 | 130 | 125 | 123 | 118 | 103 | 104 | 114 | 99 | 103 | 107 | 107 | 91 |
| EBITDA | 71 | 64 | 54 | 65 | 70 | 69 | 50 | 58 | 52 | 63 | 51 | 51 | 57 | 68 | 44 |
| Operating Profit % | 31.00% | 27.00% | 27.00% | 30.00% | 33.00% | 29.00% | 26.00% | 33.00% | 29.00% | 33.00% | 29.00% | 30.00% | 33.00% | 33.00% | 31.00% |
| Depreciation | 10 | 10 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 8 | 9 | 9 | 9 | 9 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 60 | 54 | 44 | 55 | 60 | 58 | 40 | 49 | 42 | 53 | 42 | 41 | 48 | 59 | 34 |
| Tax | 15 | 15 | 17 | 15 | 15 | 15 | 10 | 14 | 9 | 14 | 10 | 12 | 13 | 16 | 9 |
| Net Profit | 45 | 39 | 27 | 40 | 45 | 43 | 30 | 35 | 33 | 39 | 32 | 29 | 35 | 43 | 25 |
| EPS | 3.84 | 3.31 | 2.37 | 3.57 | 3.87 | 3.80 | 2.53 | 3.05 | 2.94 | 3.36 | 2.87 | 2.58 | 3.08 | 3.74 | 2.19 |
Advanced Enzyme Tech Cash Flow Screener - Liquidity Fundamentals
Screen ADVENZYMES cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 157 | 143 | 141 | 140 | 122 | 163 | 141 | 129 | 116 | 107 |
| Investing Activities | -72 | -90 | -65 | -286 | 2 | -27 | -43 | -124 | -60 | -60 |
| Financing Activities | -70 | -73 | -59 | -26 | -49 | -26 | -39 | -43 | -2 | -65 |
| Net Cash Flow | 15 | -20 | 17 | -171 | 75 | 109 | 60 | -38 | 54 | -18 |
Advanced Enzyme Tech Shareholding Pattern Screener
See Advanced Enzyme Tech shareholding pattern with promoter, FII, and DII holdings.
Check Advanced Enzyme Tech promoter holding and ownership changes for ADVENZYMES on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 43.26% | 43.24% | 43.08% | 43.08% | 43.07% | 43.04% | 43.49% | 43.02% |
| FII Holding | 25.49% | 26.71% | 11.90% | 23.46% | 25.41% | 25.86% | 23.01% | 12.03% |
| DII Holding | 5.41% | 4.78% | 8.19% | 8.45% | 6.41% | 5.51% | 7.56% | 8.08% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 17.57% | 16.94% | 16.68% | 16.92% | 16.95% | 17.44% | 15.43% | 16.42% |
| Other Holding | 8.26% | 8.33% | 20.16% | 8.10% | 8.15% | 8.15% | 10.51% | 20.45% |
| Shareholder Count | 66,193 | 63,599 | 65,322 | 67,589 | 69,637 | 68,051 | 68,640 | 65,222 |
Advanced Enzyme Tech Share Dividend Screener - Share Yield Analysis
Check Advanced Enzyme Tech dividend history with payout and yield data.
View Advanced Enzyme Tech dividend details including ex-dates and amounts for ADVENZYMES stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹5.35 | 1.75% |
| 2025-March | ₹5.20 | 2.04% |
| 2024-March | ₹5.10 | 1.83% |
| 2023-March | ₹1.00 | 0.29% |
| 2022-March | ₹1.00 | 0.42% |
| 2021-March | ₹0.90 | 0.32% |
| 2020-March | ₹0.60 | 0.17% |
| 2019-March | ₹0.60 | 0.42% |
| 2018-March | ₹0.50 | 0.27% |
| 2017-March | ₹0.40 | 0.19% |
Advanced Enzyme Tech Stock Index Membership
See which indices include Advanced Enzyme Tech stock.
Check ADVENZYMES index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Advanced Enzyme Tech Market Events Screener - Corporate Actions
Get Advanced Enzyme Tech corporate actions including splits, bonuses, and buybacks.
Check Advanced Enzyme Tech stock events that may affect ADVENZYMES share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-08 | 2026-08-08 | Quarterly Result Announcement | NA | 2.95% |
| 2026-07-31 | 2026-07-31 | Annual General Meeting | NA | -2.49% |
| 2026-07-24 | 2026-07-24 | Dividend | ₹ 1.35 /share | -12.04% |
| 2026-05-09 | 2026-05-09 | Quarterly Result Announcement | NA | 2.67% |
| 2026-01-31 | 2026-01-31 | Quarterly Result Announcement | NA | 9.05% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -3.24% |
| 2025-08-02 | 2025-08-02 | Quarterly Result Announcement | NA | 9.08% |
| 2025-07-30 | 2025-07-30 | Annual General Meeting | NA | 17.48% |
| 2025-07-23 | 2025-07-23 | Dividend | ₹ 1.20 /share | 14.47% |
| 2025-05-16 | 2025-05-17 | Dividend | ₹ 4.00 /share | -2.19% |
| 2025-05-13 | 2025-05-13 | Quarterly Result Announcement | NA | 3.73% |
| 2025-02-08 | 2025-02-08 | Quarterly Result Announcement | NA | 0.59% |
| 2024-11-09 | 2024-11-09 | Quarterly Result Announcement | NA | 8.58% |
| 2024-07-25 | 2024-07-25 | Annual General Meeting | NA | -0.83% |
| 2024-07-18 | 2024-07-18 | Dividend | ₹ 1.10 /share | -4.39% |
Advanced Enzyme Tech Competitors Screener - Peer Comparison
Screen ADVENZYMES competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Anthem Biosciences | 50,305 | 87.83 | 2,280 | 18.12% | 592 | 74.63 |
| Advanced Enzyme Tech | 3,400 | 19.90 | 781 | 16.51% | 174 | 42.00 |
| CCME Global | 270 | -391.88 | 4 | % | 0 | 16.05 |
| Vivo Bio Tech | 43 | -15.27 | 53 | 3.55% | 4 | |
| Shree Ganesh Bio-Tech | 21 | -51.00 | 5 | -79.63% | 0 | 33.91 |
| Genomic Valley Biotech | 9 | 422.14 | 0 | -66.25% | 0 | 51.24 |
Advanced Enzyme Tech Company Announcements - News Screener
Screen ADVENZYMES latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares | - | |
| Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares | - | |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-13 | Corporate Action-Updates on Buy back | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares | - |
| 2026-08-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-09 | Corporate Action-Buy back | - |
| 2026-08-09 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-08-09 | Unaudited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-09 | Board Meeting Outcome for Outcome Of Board Meeting Held On August 08 2026 | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-01 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-08-01 | Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For Quarter Ended June 30 2026 And Proposal Of Buyback Of Equity Shares. | - |
| 2026-07-31 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-07-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-08 | Copy Of Letter Sent To The Shareholders Pursuant To Regulation 36(1)(B) Of SEBI (LODR) Regulations 2015 | - |